Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
<p>Abstract</p> <p>Background</p> <p>In spite of enhanced control efforts, malaria remains a major public health problem causing close to a million deaths annually. With support from several donors, large amounts of artemisinin-based combination therapy (ACT) are being...
Main Authors: | Van Erps Jan, Olsson Sten, Dodoo Alex NO, Kuemmerle Andrea, Burri Christian, Lalvani Paul S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/10/1/57 |
Similar Items
-
Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01) -
Editorial to the Feature article “Artemisinin anti-malarial drugs in China”
by: Ao Zhang
Published: (2016-03-01) -
Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment
by: Ye Xiong, et al.
Published: (2021-08-01) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01) -
Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
by: Johanna M Porter-Kelley, et al.
Published: (2010-08-01)